Journals / İnönü Üniversitesi Turgut Özal Tıp Merkezi Dergisi / 2017 / Cilt: 24 - Sayı: 3

Review of pathophysiology, epidemiology, diagnosis and treatment methods in motion sickness; a special issue

Pages
365–370
Publication Date
2022-10-17
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The aim of this review is to remind the current knowledge about pathogenesis, epidemiology, diagnosis and treatment methods of the special issue: motion sickness.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Motion sickness (MS) is a syndrome characterized with nausea and vomiting, pallor, cold sweating, headache, dizziness, increased salivation, apathy, hyperventilation, and stomach awareness.
📊
Key Findings & Data:Nausea is one of the most prominent symptoms of MS and very little known about the neural substrate of this sensation.
💡
Conclusion & Impact:The aim of this review is to remind the current knowledge about pathogenesis, epidemiology, diagnosis and treatment methods of the special issue: motion sickness.
🔬Design:Survey & Empirical Study
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Motion sickness (MS) is a syndrome characterized with nausea and vomiting, pallor, cold sweating, headache, dizziness, increased salivation, apathy, hyperventilation, and stomach awareness. Nausea is one of the most prominent symptoms of MS and very little known about the neural substrate of this sensation. There is no abrupt accepted explanation about why people get motion sickness. It has long been suspected that genetic and /or evoluntary factors govern motion sickness susceptibility. The prevalence is higher among the female gender. The main causes in adulthood are still unknown, but it has been suggested that this condition can be related to the hormonal cycle. Patients with migraine and Meniere’s disease are prone to experience MS especially in female patients. MS is a common physiological response to real or virtual motion. Numerous studies have investigated the neurobiological mechanism and the control measures of MS. The sensory conflict hypothesis is the most widely accepted theory for MS. Questionnaires, hearth rate variability and electrogastrogram are useful for diagnosis and evaluating MS. Habitual training and drugs are the treatment modalities. The drugs can be divided into the categories: antimuscarinics, H1 antihistamines, and sempathomimetics. The aim of this review is to remind the current knowledge about pathogenesis, epidemiology, diagnosis and treatment methods of the special issue: motion sickness.

🔖

Cite This Article

BAYİNDİR, T., KOCA, C. F. (2022). Review of pathophysiology, epidemiology, diagnosis and treatment methods in motion sickness; a special issue. İnönü Üniversitesi Turgut Özal Tıp Merkezi Dergisi, Cilt: 24 - Sayı: 3, 365–370. https://ajindex.com/articles/549085

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Varlet M, Bardy BG, Chen FC, Alcantara C, Stoffregen TA. Coupling of postural activity with motion of a ship at sea. Exp Brain Res 2015;233:1607-16. Wolffgram T. Motion-and seasickness (Kinetosis)–Update on pathophysiology, prophylaxis and therapy. Medizinische Welt 2000;132(36):21-7.
  2. Golding JF, Gresty MA. Pathophysiology and treatment of motion sickness. Curr Opin Neurol 2015;28(1):83-8.
  3. Chiarella G, Petrolo C, Cassandro E. The genetics of Meniere’s disease. Appl Clin Genet 2015;8:9-17.
  4. Ferrari MD, Klever RR, Terwindt GM, Ayata C, van den Maagdenberg AM. Migraine pathophysiology: Lessons from mouse models and human genetics. Lancet Neurol 2015;14(1):65-80.
  5. Sharon JD, Hullar TE. Motion sensitivity and caloric responsiveness in vestibular migraine and Meniere’s disease. Laryngoscope 2014;124(4):969-73.
  6. Persico AM, Verdecchia M, Pinzone V, Guidetti V. Migraine genetics: Current findings and future lines of research. Neurogenetics 2015;16(2):77-95.
  7. Finley JC Jr, O’Leary M, Wester D, MacKenzie S, Shepard N, Farrow S. et al. A genetic polymorphism of the alpha2- adrenergic receptor increases autonomic responses to stress. J Appl Physiol (1985) 2004;96(6):2231-9. Oman CM. Are evolutionary hypotheses for motion sickness “just-so” stories? J Vestib Res 2012;22(2):117-27.
  8. Murdin L, Golding J, Bronstein A: Managing motion sickness. BMJ 2011;2;343:d7430. Morrow GR. The effect of a susceptibility to motion sickness on theside effects of cancer chemotherapy. Cancer 1985;55(12):2766–70.
  9. Golding, JF, Gresty, MA, Motion sickness. Curr Opin Neurol 2005;18(1):29–34.
  10. Takahashi M, Toriyabe I, Takei Y, Kanzaki J. Study on experimental motion sickness in children. Acta Otolaryngologica 1994;114(3):231-7.
  11. Chan G, Moochhala SM, Zhao B, Wl Y, Wong J. A comparison of motion sickness prevalence between seafarers and non-seafarers onboard naval platforms. Int Marit Health 2006;57(1-4):56-65.
  12. Femia P, Gonzalez del Pino B, Pérez-Fernández N. Vestibular examinationof children with alterations in balance (I): clinical and instrumental examination methods. Acta Otorrinolaringol Esp 2011;62(4):311-7. Browins B. Motion sickness: a negative reinforcement model. Brain Res Bull 2010;81(1):7-11.
  13. Golding JF, Kadzere P, Gresty MA. Motion sickness susceptibility fluctuates through the menstrual cycle. Aviat Space Environ Med 2005;76(10):970–3.
  14. Castro AS, Gazzola JM, Natour J, Ganança FF Brazilianversion of the Dizziness Handicap Inventory. Pro Fono 2007;19(1)97-104.
  15. Benson AJ, Motion sickness. In